Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BINGO: GEMOX +/- Cetuximab in Advanced Biliary Cancer
NCT00552149Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Oct 2007
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in biliary tract cancer (BTC), sponsored by Gustave Roussy. Started Oct 2007; status: completed.
02
Drugs
KL-140
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00552149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552149.